Novo Nordisk A/S
Antibodies and use thereof
Last updated:
Abstract:
The present invention relates to specific antibodies and use thereof, such as for identifying and/or quantifying liraglutide fibrils and/or semaglutide fibrils.
Status:
Grant
Type:
Utility
Filling date:
31 Mar 2020
Issue date:
28 Dec 2021